Introduction: Cerebral small-vessel disease (CSVD) is a common cause of cognitive decline and stroke. Several studies have shown that smoking is a risk factor for CSVD progression. However, the extent to which smoking exacerbates CSVD lesions remains unclear. In this study, we aimed to clarify the association between total smoking exposure and the severity of CSVD in healthy participants. Methods: We analyzed the data of participants aged ≥50 years who underwent brain screening. The participants’ age, sex, body mass index, alcohol consumption history, and medical history (hypertension, diabetes mellitus, and dyslipidemia) were investigated. Smoking status was assessed in pack-years, and smokers were classified as current or past smokers. CSVD findings on magnetic resonance imaging were used to evaluate the severity of periventricular hyperintensity (PVH), deep subcortical white matter hyperintensity (DSWMH), and enlarged perivascular spaces (EPVSs). The EPVSs were measured in the basal ganglia and centrum semiovale regions. Multivariable ordinal logistic regression analyses were performed to evaluate the effect of smoking, adjusted for the participants’ baseline characteristics. Results: A total of 2,137 participants were included in this study. The mean age of the participants was 58.7 years. The mean pack-years were 20.5 for past smokers and 26.8 for current smokers. Among current smokers, increased pack-years were significantly associated with a high EPVS burden in the basal ganglia (odds ratio: 1.14, 95% confidence interval: 1.00–1.28), whereas no such significant association was found for past smokers. No statistically significant association was found between pack-years and the risks of PVH, DSWMH, or EPVS in the centrum semiovale. Conclusion: Current smoking was associated with a dose-dependent risk of EPVS in the basal ganglia in healthy participants.

1.
Chen
X
,
Wang
J
,
Shan
Y
,
Cai
W
,
Liu
S
,
Hu
M
, et al
.
Cerebral small vessel disease: neuroimaging markers and clinical implication
.
J Neurol
.
2019
;
266
(
10
):
2347
62
.
2.
Chojdak-Lukasiewicz
J
,
Dziadkowiak
E
,
Zimny
A
,
Paradowski
B
.
Cerebral small vessel disease: a review
.
Adv Clin Exp Med
.
2021
;
30
(
3
):
349
56
.
3.
Meguro
K
,
Yamaguchi
T
,
Hishinuma
T
,
Miyazawa
H
,
Ono
S
,
Yamada
K
, et al
.
Periventricular hyperintensity on magnetic resonance imaging correlated with brain ageing and atrophy
.
Neuroradiology
.
1993
;
35
(
2
):
125
9
.
4.
Okar
SV
,
Hu
F
,
Shinohara
RT
,
Beck
ES
,
Reich
DS
,
Ineichen
BV
.
The etiology and evolution of magnetic resonance imaging-visible perivascular spaces: systematic review and meta-analysis
.
Front Neurosci
.
2023
;
17
:
1038011
.
5.
Morita
A
.
Value of Brain Dock (brain screening) system in Japan
.
World Neurosurg
.
2019
;
127
:
502
.
6.
Rigotti
NA
,
Clair
C
.
Managing tobacco use: the neglected cardiovascular disease risk factor
.
Eur Heart J
.
2013
;
34
(
42
):
3259
67
.
7.
Kim
SH
,
Yun
CH
,
Lee
SY
,
Choi
KH
,
Kim
MB
,
Park
HK
.
Age-dependent association between cigarette smoking on white matter hyperintensities
.
Neurol Sci
.
2012
;
33
(
1
):
45
51
.
8.
Lara
FR
,
Scruton
AL
,
Pinheiro
A
,
Demissie
S
,
Parva
P
,
Charidimou
A
, et al
.
Aging, prevalence and risk factors of MRI-visible enlarged perivascular spaces
.
Aging
.
2022
;
14
(
17
):
6844
58
.
9.
Bernaards
CM
,
Twisk
JW
,
Snel
J
,
Van Mechelen
W
,
Kemper
HC
.
Is calculating pack-years retrospectively a valid method to estimate life-time tobacco smoking? A comparison between prospectively calculated pack-years and retrospectively calculated pack-years
.
Addiction
.
2001
;
96
(
11
):
1653
61
.
10.
Kanda
Y
.
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
.
Bone Marrow Transplant
.
2013
;
48
(
3
):
452
8
.
11.
Duering
M
,
Biessels
GJ
,
Brodtmann
A
,
Chen
C
,
Cordonnier
C
,
de Leeuw
FE
, et al
.
Neuroimaging standards for research into small vessel disease-advances since 2013
.
Lancet Neurol
.
2023
;
22
(
7
):
602
18
.
12.
Fanning
JP
,
Wong
AA
,
Fraser
JF
.
The epidemiology of silent brain infarction: a systematic review of population-based cohorts
.
BMC Med
.
2014
;
12
:
119
.
13.
Jeerakathil
T
,
Wolf
PA
,
Beiser
A
,
Hald
JK
,
Au
R
,
Kase
CS
, et al
.
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study
.
Stroke
.
2004
;
35
(
8
):
1831
5
.
14.
de Leeuw
FE
,
de Groot
JC
,
Achten
E
,
Oudkerk
M
,
Ramos
LM
,
Heijboer
R
, et al
.
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study
.
J Neurol Neurosurg Psychiatry
.
2001
;
70
(
1
):
9
14
.
15.
Evans
TE
,
Knol
MJ
,
Schwingenschuh
P
,
Wittfeld
K
,
Hilal
S
,
Ikram
MA
, et al
.
Determinants of perivascular spaces in the general population: a pooled cohort analysis of individual participant data
.
Neurology
.
2023
;
100
(
2
):
e107
22
.
16.
Wharton
SB
,
Simpson
JE
,
Brayne
C
,
Ince
PG
.
Age-associated white matter lesions: the MRC cognitive function and ageing study
.
Brain Pathol
.
2015
;
25
(
1
):
35
43
.
17.
Power
MC
,
Deal
JA
,
Sharrett
AR
,
Jack
CR
Jr
,
Knopman
D
,
Mosley
TH
, et al
.
Smoking and white matter hyperintensity progression: the ARIC-MRI Study
.
Neurology
.
2015
;
84
(
8
):
841
8
.
18.
Akashi
T
,
Takahashi
S
,
Mugikura
S
,
Sato
S
,
Murata
T
,
Umetsu
A
, et al
.
Ischemic white matter lesions associated with medullary arteries: classification of MRI findings based on the anatomic arterial distributions
.
AJR Am J Roentgenol
.
2017
;
209
(
3
):
W160
8
.
19.
Ineichen
BV
,
Cananau
C
,
Platten
M
,
Ouellette
R
,
Moridi
T
,
Frauenknecht
KBM
, et al
.
Dilated Virchow-Robin spaces are a marker for arterial disease in multiple sclerosis
.
EBioMedicine
.
2023
;
92
:
104631
.
20.
Pham
W
,
Lynch
M
,
Spitz
G
,
O'Brien
T
,
Vivash
L
,
Sinclair
B
, et al
.
A critical guide to the automated quantification of perivascular spaces in magnetic resonance imaging
.
Front Neurosci
.
2022
;
16
:
1021311
.
You do not currently have access to this content.